|
||||||
 |
||||||
Our Company
Market OpportunitiesToday’s environment contains many sources of microbial contamination, both natural and man-made, that cause great concern. Contaminants can be the origin of minor infection or potentially the source of life threatening illness. In recent years, the public has become much more aware of this threat, and regularly seek assurance that the chance of disease transmission is minimized. Increased awareness of potential disease transmission by both medical and lay communities, and growing pressure to reduce this potential disease transmission, has resulted in a market for decontamination products totaling well over a billion dollars per year. In response to this continually increasing market, a growing number of products designed to kill potential contaminants are becoming available. These products touch all areas of our lives, reaching from the household to the hospital. Decontaminants are commonly used by the medical, veterinary, aviation, janitorial, food service and the leisure (hotels and cruise ships) industries, as well as the military. However, the vast majority of these products represent challenges to the environment as evidenced by the warnings on their labels. This conflict between efficacy and safety has resulted in a dilemma for the consumer, and an opportunity for EnviroSystems, Inc. EnviroSystems is directed by its mission to become a worldwide leader in the development and commercialization of products designed to prevent the spread of infectious microorganisms while minimizing the harmful effects to users, surfaces and the environment. ESI will deploy its technology and resources to reduce biological risks without introducing the attendant chemical risks that are so prevalent today. Infectious diseases are the leading cause of death in the world and 3rd in the United States. The US demand for infection prevention products & services was $10.3 billion in 2006 — growing 4.6% annually to $11.8 billion in 2009 with consumables/disposables constituting 91% of that number. The U.S. disinfectants demand will grow from $2.2 billion to $2.5 billion in the same period. Hospital acquired infections affect 2 million people annually, causing 80,000 deaths in the US per year, at a direct cost over $4.5 billion annually. Eighty million cases of food poisoning occur annually in the US with associated costs of $7.6—$23 billion. Threats of pandemic or bioterrorist attack and health safety after hurricanes, tornadoes, and other natural disasters pose enormous infection prevention challenges. Those challenges coupled with growing concerns over the safety of present cleaning and decontamination products used in public places (causes for allergic and asthmatic type reactions) has resulted in a significant market opportunity for decontamination products with an efficacy/safety profile. With an Infection Prevention Market focus, ESI intends to build a platform of products focused on niche markets and private labeling where possible. The Company will do so by developing a strong domestic and international distribution network with an internal support infrastructure and employing its proprietary emulsion technology and securing/developing technologies/products that:
|
||||||